Form 4 for XFOR X4 Pharmaceuticals, Inc
Accepted 2022-06-27 00:00:00 ET · period of report 2022-06-06 · accession 0001628280-22-018052 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-06-27 | 2022-06-06 | XFOR | WYZGA MICHAEL S | Dir | A - Grant | $0.00 | +6,667 | 6,667 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-06-06 | A | A | 6,667 | $0.00 | 6,667 | D | — | — | (F1) Represents an annual grant of restricted stock units ("RSUs") for service as a director to the Issuer. The RSUs will vest in two equal annual installments on June 6, 2023 and June 6, 2024, subject to the Reporting Person continuing to provide service to the Issuer through the applicable vesting date. (F2) Represents unvested RSUs. |